Skip Navigation


Glycobiology Advance Access originally published online on June 22, 2005
Glycobiology 2005 15(11):1125-1135; doi:10.1093/glycob/cwi097
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
15/11/1125    most recent
cwi097v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tateno, H.
Right arrow Articles by Paulson, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tateno, H.
Right arrow Articles by Paulson, J. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oupjournals.org

Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand

Hiroaki Tateno2, Paul R. Crocker3 and James C. Paulson1,2

2 Department of Molecular Biology, The Scripps Research Institute, San Diego, CA 92037; and 3 Division of Cell Biology and Immunology, The Wellcome Trust Biocentre, School of Life Sciences, University of Dundee, Dundee DD1 5EH, Scotland, UK

1 To whom correspondence should be addressed; e-mail: jpaulson{at}scripps.edu

Received on May 11, 2005; revised on June 17, 2005; accepted on June 19, 2005

Mouse sialic acid-binding immunoglobulin-like lectin F (Siglec-F) is an eosinophil surface receptor, which contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) in its cytoplasmic domain, implicating it as a regulator of cell signaling as documented for other siglecs. Here, we show that the sialoside sequence 6'-sulfo-sLeX (Neu5Ac{alpha}2–3[6-SO4] Galß1–4[Fuc{alpha}1–3]GlcNAc) is a preferred ligand for Siglec-F. In glycan array analysis of 172 glycans, recombinant Siglec-F-Fc chimeras bound with the highest avidity to 6'-sulfo-sLeX. Secondary analysis showed that related structures, sialyl-Lewis X (sLeX) and 6-sulfo-sLeX containing 6-GlcNAc-SO4 showed much lower binding avidity, indicating significant contribution of 6-Gal-SO4 on Siglec-F binding to 6'-sulfo-sLex. The lectin activity of Siglec-F on mouse eosinophils was "masked" by endogenous cis ligands and could be unmasked by treatment with sialidase. Unmasked Siglec-F mediated mouse eosinophil binding and adhesion to multivalent 6'-sulfo-sLeX structure, and these interactions were inhibited by anti-Siglec-F monoclonal antibody (mAb). Although there is no clear-cut human ortholog of Siglec-F, Siglec-8 is encoded by a paralogous gene that is expressed selectively by human eosinophils and has recently been found to recognize 6'-sulfo-sLeX. These observations suggest that mouse Siglec-F and human Siglec-8 have undergone functional convergence during evolution and implicate a role for the interaction of these siglecs with their preferred 6'-sulfo-sLeX ligand in eosinophil biology.

Key words: 6'-sulfo-sialyl-Lewis X / eosinophils / functionally convergent paralog / Siglec-8 / Siglec-F


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
H. Tateno, H. Li, M. J. Schur, N. Bovin, P. R. Crocker, W. W. Wakarchuk, and J. C. Paulson
Distinct Endocytic Mechanisms of CD22 (Siglec-2) and Siglec-F Reflect Roles in Cell Signaling and Innate Immunity
Mol. Cell. Biol., August 15, 2007; 27(16): 5699 - 5710.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. D. Dyer, M. Czapiga, B. Foster, P. S. Foster, E. M. Kang, C. M. Lappas, J. M. Moser, N. Naumann, C. M. Percopo, S. J. Siegel, et al.
Eosinophils from Lineage-Ablated {Delta}dblGATA Bone Marrow Progenitors: The dblGATA Enhancer in the Promoter of GATA-1 Is Not Essential for Differentiation Ex Vivo
J. Immunol., August 1, 2007; 179(3): 1693 - 1699.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
T. Avril, S. J. North, S. M. Haslam, H. J. Willison, and P. R. Crocker
Probing the cis interactions of the inhibitory receptor Siglec-7 with {alpha}2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of {alpha}2,8-sialyltransferase gene expression
J. Leukoc. Biol., October 1, 2006; 80(4): 787 - 796.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. S. Powlesland, E. M. Ward, S. K. Sadhu, Y. Guo, M. E. Taylor, and K. Drickamer
Widely Divergent Biochemical Properties of the Complete Set of Mouse DC-SIGN-related Proteins
J. Biol. Chem., July 21, 2006; 281(29): 20440 - 20449.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Yamada, M. E. Rothenberg, A. W. Lee, H. S. Akei, E. B. Brandt, D. A. Williams, and J. A. Cancelas
The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease
Blood, May 15, 2006; 107(10): 4071 - 4079.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
R. Raman, M. Venkataraman, S. Ramakrishnan, W. Lang, S. Raguram, and R. Sasisekharan
Advancing glycomics: Implementation strategies at the Consortium for Functional Glycomics
Glycobiology, May 1, 2006; 16(5): 82R - 90R.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. M. Reiman, R. W. Thompson, C. G. Feng, D. Hari, R. Knight, A. W. Cheever, H. F. Rosenberg, and T. A. Wynn
Interleukin-5 (IL-5) Augments the Progression of Liver Fibrosis by Regulating IL-13 Activity
Infect. Immun., March 1, 2006; 74(3): 1471 - 1479.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.